Alzheimer's Accountability Act of 2014

Bill: 113-s-2192
Sponsor: full_name: Sen. Markey, Edward J. [D-MA]
Introduced: 2014-04-01
Policy area: Health
Subjects: Congressional oversight

Department of Health and Human Services

Executive agency funding and structure

Government employee pay, benefits, personnel management

Health programs administration and funding

National Institutes of Health (NIH)

Neurological disorders
Latest action: action_date: 2014-04-01
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2014-04-01
action_desc: Introduced in Senate
text: <p>Alzheimer's Accountability Act of 2014 - Amends the National Alzheimer's Project Act to require the Director of the National Institutes of Health (NIH), for each fiscal year through FY2025, to submit to the President for review and transmittal to Congress, after reasonable opportunity for comment (but without change) by the Secretary of Health and Human Services (HHS) and the Advisory Council on Alzheimer's Research, Care, and Services, an annual budget estimate (including regarding personnel needs) for the NIH initiatives under the Act.</p>

tv_txt: II 113th CONGRESS 2d Session S. 2192 IN THE SENATE OF THE UNITED STATES April 1, 2014 Mr. Markey (for himself and Mr. Crapo ) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To amend the National Alzheimer’s Project Act to require the Director of the National Institutes of Health to prepare and submit, directly to the President for review and transmittal to Congress, an annual budget estimate (including an estimate of the number and type of personnel needs for the Institutes) for the initiatives of the National Institutes of Health pursuant to such Act.

1. Short title This Act may be cited as the Alzheimer's Accountability Act of 2014. . 2. Findings The Congress finds as follows: (1) Alzheimer’s disease is the most expensive disease in the United States today. Its costs are set to increase like the costs of no other disease and will be carried in substantial measure through the Medicare and Medicaid programs. (2) Through the unanimous, bipartisan passage of the National Alzheimer's Project Act (Public Law 111–375), the 111th Congress recognized the national imperative to act and instructed the Nation's scientists to develop a plan to change the trajectory of this disease. (3) Scientists at the National Institutes of Health have prepared and presented to Congress a national plan to prevent and effectively treat Alzheimer's disease by 2025, including the underlying specification of milestones and timelines to achieve this goal. (4) Capital budgeting is a universally accepted best practice for the successful management of such a multiyear project, but such projections have not been prepared and provided to Congress to achieve the 2025 goal, preventing Congress from exercising truly effective oversight over a venture of profound importance to the Nation. 3. Professional judgment budget for initiatives of NIH under national alzheimer's project Section 2 of the National Alzheimer’s Project Act ( Public Law 111–375 ) ( 41 U.S.C. 11225 ) is amended— (1) by redesignating subsection (h) as subsection (i); and (2) by inserting after subsection (g) the following: (h) Professional judgment budget For each fiscal year through fiscal year 2025, the Director of the National Institutes of Health shall prepare and submit, directly to the President for review and transmittal to Congress, after reasonable opportunity for comment (but without change) by the Secretary of Health and Human Services and the Advisory Council, an annual budget estimate (including an estimate of the number and type of personnel needs for the Institutes) for the initiatives of the National Institutes of Health pursuant to this Act. .